DEN Group’s Sale of Talliosake

Borenius advised DEN Group on the deal. DEN Group secured the sale of Talliosake to a group of investors formed by former entrepreneurs of Talliosake Oy....

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Aiforia’s Directed Share Offering

Borenius advised Aiforia on the deal. Aiforia Technologies Plc completed a directed share issuance of approximately EUR 10 million through an accelerated book building procedure. The...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Teva Pharmaceuticals’ Patent Dispute

Borenius advised Teva Pharmaceuticals on the case. Teva Pharmaceuticals partecipated in a patent dispute before the Finnish Market Court concerning Bristol-Myers Squibb Holdings Ireland Unlimited Company’s...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Nanoform’s Shares Offering

Borenius advised Nanoform on the offering. Nanoform Finland Plc secured a directed share issuance of approximately EUR 15 million through an accelerated book building procedure. Nanoform...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here